Trial Profile
Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Apr 2020
Price :
$35
*
At a glance
- Drugs Orlistat (Primary)
- Indications Binge-eating disorder; Obesity
- Focus Therapeutic Use
- 29 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 02 Feb 2009 New trial record